Type
Business expansion
Country
Ireland
Region
Southern and Eastern; South-East (IRL);
Location of affected unit(s)
Waterford
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

165 jobs
Number of planned job creations
Job creation
Announcement Date
3 March 2008
Employment effect (start)
Foreseen end date
1 March 2013

Description

IVAX Pharmaceuticals has announced that it will create 165 jobs over the next five years in Waterford. The EUR 65 million investment will enable the Waterford pharmaceutical firm to more than double both its inhaler and tablet manufacturing capacity relating to the relief and prevention of asthma. The asthma products manufactured in Waterford are exported worldwide. The SIPTU trade union has described the investment as “a real vote of confidence in the skills and commitment of the existing workforce”. According to the union, “as IVAX Pharmaceuticals is a highly unionised plant, their expansion plans dispel the myth that unions are anathema to business. It proves that management and unions can work together”.


Sources

Citation

Eurofound (2008), IVAX Pharmaceuticals Ireland, Business expansion in Ireland, factsheet number 66368, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66368.